Novartis' influenza vaccine business
GPTKB entity
Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:business
|
| gptkbp:acquired |
gptkb:Chiron_Corporation
|
| gptkbp:aims_to |
improve vaccine accessibility
enhance vaccine production reduce influenza outbreaks |
| gptkbp:collaborates_with |
health organizations
|
| gptkbp:complies_with |
gptkb:regulations
|
| gptkbp:contributes_to |
global vaccination efforts
|
| gptkbp:develops |
vaccine technologies
|
| gptkbp:employs |
gptkb:scientists
|
| gptkbp:focuses_on |
public health
|
| gptkbp:has_achieved |
various certifications
|
| gptkbp:has_collaborations_with |
academic institutions
|
| gptkbp:has_developed |
adjuvanted vaccines
|
| gptkbp:has_part |
gptkb:supply_chain_management
marketing strategies supply chain logistics manufacturing facilities patient education programs quality control processes regulatory affairs team clinical research teams vaccine pipeline |
| gptkbp:headquartered_in |
gptkb:Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Novartis' influenza vaccine business
|
| gptkbp:investment |
research and development
|
| gptkbp:is_committed_to |
sustainable practices
|
| gptkbp:is_engaged_in |
community outreach programs
public awareness campaigns |
| gptkbp:is_focused_on |
vaccine efficacy
vaccine development timelines |
| gptkbp:is_involved_in |
vaccine distribution
international health initiatives vaccine innovation vaccine safety monitoring healthcare partnerships vaccine education efforts |
| gptkbp:is_known_for |
innovative vaccine solutions
|
| gptkbp:is_part_of |
biopharmaceutical industry
global health strategies |
| gptkbp:is_recognized_by |
health authorities
|
| gptkbp:is_recognized_for |
contributions to immunization
|
| gptkbp:is_supported_by |
gptkb:scientific_research
government funding |
| gptkbp:offers |
seasonal flu vaccines
pandemic flu vaccines |
| gptkbp:part_of |
gptkb:Novartis_AG
|
| gptkbp:participates_in |
clinical trials
|
| gptkbp:produces |
influenza vaccines
|
| gptkbp:targets |
high-risk populations
|
| gptkbp:utilizes |
cell culture technology
|
| gptkbp:bfsParent |
gptkb:CSL_Limited
|
| gptkbp:bfsLayer |
6
|